Results 171 to 180 of about 12,335 (206)

Tumor Immunotherapy Targeting B7-H3: From Mechanisms to Clinical Applications. [PDF]

Immunotargets Ther
Guo Y, Wang X, Zhang C, Chen W, Fu Y, Yu Y, Chen Y, Shao T, Zhang J, Ding G.   +9 more
europepmc   +1 more source

Preclinical Evaluation of DB-1419, a Novel Bifunctional and Bispecific Anti-B7-H3 × PD-L1 Antibody-Drug Conjugate. [PDF]

Clin Cancer Res
Li C, Yao J, Yang J, Zhang Y, Qiu Y, Zhu Z, Hua H.   +6 more
europepmc   +1 more source

B7-H3 as a Reliable Diagnostic Biomarker for the Differentiation of High-Grade Gliomas (HGGs) and Low-Grade Gliomas (LGGs). [PDF]

Brain Sci
Juković-Bihorac F, Đuričić S, Begagić E, Bečulić H, Efendić A, Vranić S, Pojskić M.   +6 more
europepmc   +1 more source

B7-H3 and c-MET in advanced prostate cancer: exploring possibilities of novel bi-specific drug development. [PDF]

Eur J Med Res
He W, Li H, Sun W, Zhang Y, Wu, Ao C, Wang J, Yang Y, Xiao X, Zhang L, Yue J, Wang X.   +11 more
europepmc   +1 more source

Prognostic Value of B7-H3 and a Novel Scoring System in Localized Renal Cell Carcinoma. [PDF]

Medicina (Kaunas)
Özalp FR, Yörükoğlu K, Çalışkan Yıldırım E, Uzun M, Demirciler E, Semiz HS.   +5 more
europepmc   +1 more source

Computational structural optimization enhances IL13Rα2 - B7-H3 tandem CAR T cells to overcome antigen-heterogeneity-mediated tumor escape. [PDF]

Mol Ther
Meehl MM, Immadisetty K, Trivedi VD, Glowacki P, Prinzing B, Anido AA, Ibañez-Vega J, Leslie BJ, Babu MM, Krenciute G.   +9 more
europepmc   +1 more source

A Phase I, Open-Label, Dose Escalation Study of Enoblituzumab in Children and Young Adults with B7-H3-Expressing Relapsed or Refractory Solid Tumors. [PDF]

Cancer Res Commun
DeSantes KB, McDowell KA, Sondel PM, Hutson PR, Kaplan RN, Park JR, Hegde MG, Mackall CL, Maris JM.   +8 more
europepmc   +1 more source

Correction to "Identification of c-Met on Tumor Cells as a Novel Receptor for B7-H3 Entails Implications for Cancer Cell Stemness and Targeted Therapy". [PDF]

MedComm (2020)
europepmc   +1 more source

Identification of the B7-H3 Interaction Partners Using a Proximity Labeling Strategy. [PDF]

Int J Mol Sci
Liao S, Huang J, Lupala CS, Li X, Li X, Li N.   +5 more
europepmc   +1 more source

Preclinical Evaluation of a B7-H3 Targeting Antibody Enhancing NK Cell-Mediated Cytotoxicity for Ovarian Cancer Treatment. [PDF]

Immunotargets Ther
Hagelstein I, Mattern S, Wang K, Haueisen YE, Greiner SM, Englisch A, Staebler A, Singer S, Lutz MS.   +8 more
europepmc   +1 more source